| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | Sep 3, 2025 | Spero Therapeutics, Inc. | Director | Sell | 48.8 | -6,572 | -0.93% | ✗ | $12.9K |
| Feb 5, 2025 | Feb 5, 2025 | Spero Therapeutics, Inc. | Director | Sell | 42.5 | -69,219 | -9.12% | ✗ | $54K |
| Aug 27, 2024 | Aug 29, 2024 | Spero Therapeutics, Inc. | Director | Sell | 50.0 | -5,912 | -0.77% | ✗ | $8K |
| Feb 2, 2024 | Feb 5, 2024 | Spero Therapeutics, Inc. | Director | Sell | 42.5 | -63,795 | -7.89% | ✗ | $87.4K |
| Aug 28, 2023 | Aug 30, 2023 | Spero Therapeutics, Inc. | Director | Sell | 46.3 | -9,040 | -1.13% | ✗ | $11.4K |
| Feb 3, 2023 | Feb 6, 2023 | Spero Therapeutics, Inc. | CEO | Sell | 46.3 | -12,286 | -1.52% | ✗ | $22.2K |
| Dec 27, 2021 | Dec 29, 2021 | Spero Therapeutics, Inc. | CEO | Sell | 32.5 | -8,000 | -5.26% | ✓ | $116.7K |
| Nov 3, 2020 | Nov 5, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 32.5 | -9,507 | -6.74% | ✓ | $136.8K |
| Oct 23, 2020 | Oct 27, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 58.8 | -20 | -0.03% | ✓ | $285 |
| Oct 13, 2020 | Oct 15, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 28.8 | -14,472 | -9.91% | ✓ | $206.7K |
| Sep 8, 2020 | Sep 10, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 48.8 | -774 | -1.16% | ✓ | $11K |
| Jul 7, 2020 | Jul 9, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 45.0 | -3,047 | -2.26% | ✓ | $43.6K |
| Jun 22, 2020 | Jun 29, 2020 | Spero Therapeutics, Inc. | CEO | Sell | 32.5 | -17,180 | -6.13% | ✓ | $245.7K |
| Jul 5, 2018 | Jul 6, 2018 | Spero Therapeutics, Inc. | Officer | Sell | 47.5 | -4,676 | -0.87% | ✓ | $82.4K |